BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7663347)

  • 1. Characterization of a quaternary-structured folding intermediate of an antibody Fab-fragment.
    Lilie H; Jaenicke R; Buchner J
    Protein Sci; 1995 May; 4(5):917-24. PubMed ID: 7663347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antibody chains at different stages of folding: prolyl isomerization occurs after formation of quaternary structure.
    Lilie H; Rudolph R; Buchner J
    J Mol Biol; 1995 Apr; 248(1):190-201. PubMed ID: 7731044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domain behavior during the folding of a thermostable phosphoglycerate kinase.
    Parker MJ; Spencer J; Jackson GS; Burston SG; Hosszu LL; Craven CJ; Waltho JP; Clarke AR
    Biochemistry; 1996 Dec; 35(49):15740-52. PubMed ID: 8961937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folding and oxidation of the antibody domain C(H)3.
    Thies MJ; Talamo F; Mayer M; Bell S; Ruoppolo M; Marino G; Buchner J
    J Mol Biol; 2002 Jun; 319(5):1267-77. PubMed ID: 12079363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradomain disulfide bonds impede formation of the alternatively folded state of antibody chains.
    Buchner J; Rudolph R; Lilie H
    J Mol Biol; 2002 May; 318(3):829-36. PubMed ID: 12054826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folding nuclei of the scFv fragment of an antibody.
    Freund C; Honegger A; Hunziker P; Holak TA; Plückthun A
    Biochemistry; 1996 Jun; 35(25):8457-64. PubMed ID: 8679604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability.
    Röthlisberger D; Honegger A; Plückthun A
    J Mol Biol; 2005 Apr; 347(4):773-89. PubMed ID: 15769469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization.
    Thies MJ; Mayer J; Augustine JG; Frederick CA; Lilie H; Buchner J
    J Mol Biol; 1999 Oct; 293(1):67-79. PubMed ID: 10512716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
    Jäger M; Gehrig P; Plückthun A
    J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal unfolding of an intermediate is associated with non-Arrhenius kinetics in the folding of hen lysozyme.
    Matagne A; Jamin M; Chung EW; Robinson CV; Radford SE; Dobson CM
    J Mol Biol; 2000 Mar; 297(1):193-210. PubMed ID: 10704316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the folding and unfolding reactions of single-chain monellin: evidence for multiple intermediates and competing pathways.
    Patra AK; Udgaonkar JB
    Biochemistry; 2007 Oct; 46(42):11727-43. PubMed ID: 17902706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The slow folding reaction of barstar: the core tryptophan region attains tight packing before substantial secondary and tertiary structure formation and final compaction of the polypeptide chain.
    Sridevi K; Juneja J; Bhuyan AK; Krishnamoorthy G; Udgaonkar JB
    J Mol Biol; 2000 Sep; 302(2):479-95. PubMed ID: 10970747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burst-phase intermediate in the refolding of beta-lactoglobulin studied by stopped-flow circular dichroism and absorption spectroscopy.
    Kuwajima K; Yamaya H; Sugai S
    J Mol Biol; 1996 Dec; 264(4):806-22. PubMed ID: 8980687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An early intermediate in the folding reaction of the B1 domain of protein G contains a native-like core.
    Park SH; O'Neil KT; Roder H
    Biochemistry; 1997 Nov; 36(47):14277-83. PubMed ID: 9400366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dissection of the folding mechanism of the alpha subunit of tryptophan synthase: an amino-terminal autonomous folding unit controls several rate-limiting steps in the folding of a single domain protein.
    Zitzewitz JA; Matthews CR
    Biochemistry; 1999 Aug; 38(31):10205-14. PubMed ID: 10433729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domain interactions stabilize the alternatively folded state of an antibody Fab fragment.
    Lilie H; Buchner J
    FEBS Lett; 1995 Mar; 362(1):43-6. PubMed ID: 7698350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The folding pathway of the antibody V(L) domain.
    Simpson ER; Herold EM; Buchner J
    J Mol Biol; 2009 Oct; 392(5):1326-38. PubMed ID: 19647749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation.
    Ramm K; Gehrig P; Plückthun A
    J Mol Biol; 1999 Jul; 290(2):535-46. PubMed ID: 10390351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding of the Fab fragment within the intact antibody.
    Lilie H
    FEBS Lett; 1997 Nov; 417(2):239-42. PubMed ID: 9395304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.